Simon Baker
Stock Analyst at Redburn Partners
(0.99)
# 2,725
Out of 4,479 analysts
7
Total ratings
33.33%
Success rate
2.71%
Average return
Main Sectors:
5 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BNTX BioNTech SE | Upgrades: Buy | $165 → $170 | $78.76 | +115.85% | 3 | May 17, 2023 | |
| QGEN Qiagen | Initiates: Buy | n/a | $40.70 | - | 1 | Oct 14, 2021 | |
| ABT Abbott Laboratories | Initiates: Neutral | n/a | $103.20 | - | 1 | Oct 14, 2021 | |
| HOLX Hologic | Initiates: Neutral | n/a | $73.53 | - | 1 | Oct 14, 2021 | |
| FOXA Fox Corporation | Upgrades: Hold | n/a | $34.48 | - | 1 | Apr 8, 2020 |
BioNTech SE
May 17, 2023
Upgrades: Buy
Price Target: $165 → $170
Current: $78.76
Upside: +115.85%
Qiagen
Oct 14, 2021
Initiates: Buy
Price Target: n/a
Current: $40.70
Upside: -
Abbott Laboratories
Oct 14, 2021
Initiates: Neutral
Price Target: n/a
Current: $103.20
Upside: -
Hologic
Oct 14, 2021
Initiates: Neutral
Price Target: n/a
Current: $73.53
Upside: -
Fox Corporation
Apr 8, 2020
Upgrades: Hold
Price Target: n/a
Current: $34.48
Upside: -